Hematology clinical research training program

血液学临床研究培训计划（T32 HL-07439）PI：Brass，Lawrence F. 项目摘要 宾夕法尼亚大学的血液学临床研究培训项目成立于年。 1978年，为162名男女提供了基础和转化研究培训。该计划的 主要目标是帮助不同群体的个人为职业生涯做好准备，作为广泛定义的调查员。 血液学与血液病学科。该学院包括39名所有学术级别的培训师和一个计划 在适当的时候添加或撤回培训师。每年最多接受12名新学员 （8名博士后和4名前博士）。最初的候选人主要是从注册的医生中挑选出来的。 在内科和儿科的临床血液学培训计划。自1998年以来， 自2004年以来，支持非医生的博士后学员和博士前学员，其中许多人 都参加过宾州大学的医学博士项目监督来自我们的内部监督委员会， 外部咨询委员会。连接到MD-PhD计划利用PI的作用， 也是这个项目的负责人。包括博士前学生反映了我们的长期价值的信念 让有才华的学生在科学家培训的早期参与血液学相关的研究 和物理学家科学家。该计划的基本特征包括正式和非正式的咨询，技能 讲习班、参加地方研讨会和全国会议、课程作业、负责人培训 进行研究，以及由我们的外部顾问参加的年度演示和反馈会议 董事会成员MD博士后研究员可以选择参加生物医学研究生课程（BGS） 博士课程。最近有两名研究员这样做了。结果。162名受训人员（包括目前任用的人员） 已经得到了这个计划的支持：133博士后（69 MD，24 MD-PhD和40博士）和29 predocs（19 in MD-PhD课程和10个PhD课程）。在完成所有阶段培训的131人中， 97人（74%）持有或曾经持有（3人已去世或退休）我们认为适当结果的职位 该培训计划的校友：50%在学术机构全职任职，21%在 生物技术或制药行业，1%在NIH，1%在NIH以外的研究机构，2% 在学术界或国家卫生研究院之外提供输血服务的人在学术界，76%的人有或曾经有过研究， 来自任何来源的资金，51%的人得到或曾经得到NIH的支持，HLBI至少是 半吸引和培训不同男女群体的详细计划，监测其进展情况 以个性化的发展计划为基准，并接受学员，校友和 教师是包含在应用程序中的。要求按目前水平重新提供资金。

Hematology Clinical Research Training Program (T32 HL-07439) PI: Brass, Lawrence F. PROJECT SUMMARY The Hematology Clinical Research Training Program at the University of Pennsylvania was established in 1978 and has provided basic and translational research training for 162 men and women. The program’s primary goal is to help a diverse group of individuals prepare for careers as investigators in the broadly-defined discipline of hematology and blood disorders. The faculty includes 39 trainers of all academic ranks and a plan is in place for adding or withdrawing trainers when appropriate. Up to 12 new trainees are accepted each year (8 postdocs and 4 predocs). Candidates were originally were drawn primarily from physicians enrolled in the clinical hematology training programs in the Departments of Medicine and Pediatrics. Since 1998 we have also supported postdoctoral trainees who are not physicians and, since 2004, predoctoral trainees, many of whom have been in Penn’s MD-PhD program. Oversight comes from our internal Oversight Committee and our External Advisory Board. The connection to the MD-PhD program takes advantage of the PI’s role as the director of that program as well. The inclusion of predoctoral students reflects our belief in the long term value of involving talented students to hematology-related research at an earlier point in their training as scientists and physician-scientists. Essential features of the program include formal and informal advising, skills workshops, attendance at local seminars and national conferences, coursework, training in the responsible conduct of research, and an annual presentation and feedback session attended by our external advisory board members. MD postdoctoral fellows have the option of enrolling in a Biomedical Graduate Studies (BGS) PhD program. Two recent fellows have done so. Outcomes. 162 trainees (including those currently appointed) have been supported by this program: 133 postdocs (69 MD, 24 MD-PhD and 40 PhD) and 29 predocs (19 in the MD-PhD program and 10 in a PhD program). Of the 131 who have completed all stages of training, at least 97 (74%) hold or have held (3 are deceased or retired) positions that we consider appropriate outcomes for alumni of this training program: 50% with full-time appointments at an academic institution, 21% employed in the biotech or pharmaceutical industries, 1% at the NIH, 1% at a research institute other than the NIH, and 2% who run transfusion services outside of academia or the NIH. Of those in academia, 76% have or had research funding from any source and 51% have or had NIH support, with HLBI being the source of support for at least half. A detailed plan for attracting and training a diverse group of men and women, monitoring their progress benchmarked with an individualized development plan, and receiving feedback from trainees, alumni and faculty is included in the application. Renewed funding is requested at the present level.